Aldeyra Therapeutics, Inc. - ALDX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | President and CEO | A | A | 632,318.0 | 0.0 | 0.0 | 632,318.0 | View | |
| Mar 31, 2026 | President and CEO | A | A | 1,880,510.0 | 0.0 | 0.0 | 1,880,510.0 | View | |
| Mar 20, 2026 | — | P | A | 70,000.0 | 1.4 | 98,000.0 | 195,000.0 | View | |
| Mar 19, 2026 | Principal Financial Officer | P | A | 5,000.0 | 1.42 | 7,100.0 | 7,500.0 | View |